Cargando…

Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients

BACKGROUND: Colorectal adenomatous polyps (CAPs) are considered precancerous lesions of colorectal cancer (CRC). The gut microbiota participates in the process of digestion and, in the process, produces metabolites, mainly short-chain fatty acids (SCFAs), secondary bile acids and conjugated linoleic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ciyan, Niu, Min, Pan, Junxi, Du, Na, Liu, Shumin, Li, Huanqin, He, Qiuyue, Mao, Jian, Duan, Yong, Du, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805033/
https://www.ncbi.nlm.nih.gov/pubmed/33436066
http://dx.doi.org/10.1186/s13099-020-00395-0
_version_ 1783636236132417536
author Chen, Ciyan
Niu, Min
Pan, Junxi
Du, Na
Liu, Shumin
Li, Huanqin
He, Qiuyue
Mao, Jian
Duan, Yong
Du, Yan
author_facet Chen, Ciyan
Niu, Min
Pan, Junxi
Du, Na
Liu, Shumin
Li, Huanqin
He, Qiuyue
Mao, Jian
Duan, Yong
Du, Yan
author_sort Chen, Ciyan
collection PubMed
description BACKGROUND: Colorectal adenomatous polyps (CAPs) are considered precancerous lesions of colorectal cancer (CRC). The gut microbiota participates in the process of digestion and, in the process, produces metabolites, mainly short-chain fatty acids (SCFAs), secondary bile acids and conjugated linoleic acid (CLA). This study aimed to investigate the gut microbiota constituents and metabolites in the faeces of CAP patients to identify microbiota or metabolites that can be used as sensitive biological predictors and to provide a theoretical basis for the clinical treatment of CAPs. METHODS: 16S rRNA sequence analysis was used to detect microbial changes in the faeces of CAP patients. qPCR analysis was used to evaluate the ability of the microbiota to produce metabolites, and the contents of metabolites in faeces were detected by ion chromatography and ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). RESULTS: Based on the detection of the gut microbiota, patients with CAPs had increased abundances of Bacteroides and Citrobacter, and the abundances of Weissella and Lactobacillus were decreased. We also explored gene expression, and the abundance of butyrate-producing bacterial genes was significantly increased in the faeces of CAP patients, but those of secondary bile acid-producing and CLA-producing bacterial genes showed no differences in faecal samples. The acetic acid and butyric acid contents were increased in the faeces of the CAP group, and the healthy control group had higher t10,c12-CLA contents. CONCLUSION: The gut microbiota analysis results, assessed in faeces, showed that Bacteroides and Citrobacter were positively correlated with CAPs, which indicated that changes in specific genera might be detrimental to intestinal health. In addition, t10,c12-CLA played an important role in protecting the intestine.
format Online
Article
Text
id pubmed-7805033
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78050332021-01-14 Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients Chen, Ciyan Niu, Min Pan, Junxi Du, Na Liu, Shumin Li, Huanqin He, Qiuyue Mao, Jian Duan, Yong Du, Yan Gut Pathog Research BACKGROUND: Colorectal adenomatous polyps (CAPs) are considered precancerous lesions of colorectal cancer (CRC). The gut microbiota participates in the process of digestion and, in the process, produces metabolites, mainly short-chain fatty acids (SCFAs), secondary bile acids and conjugated linoleic acid (CLA). This study aimed to investigate the gut microbiota constituents and metabolites in the faeces of CAP patients to identify microbiota or metabolites that can be used as sensitive biological predictors and to provide a theoretical basis for the clinical treatment of CAPs. METHODS: 16S rRNA sequence analysis was used to detect microbial changes in the faeces of CAP patients. qPCR analysis was used to evaluate the ability of the microbiota to produce metabolites, and the contents of metabolites in faeces were detected by ion chromatography and ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). RESULTS: Based on the detection of the gut microbiota, patients with CAPs had increased abundances of Bacteroides and Citrobacter, and the abundances of Weissella and Lactobacillus were decreased. We also explored gene expression, and the abundance of butyrate-producing bacterial genes was significantly increased in the faeces of CAP patients, but those of secondary bile acid-producing and CLA-producing bacterial genes showed no differences in faecal samples. The acetic acid and butyric acid contents were increased in the faeces of the CAP group, and the healthy control group had higher t10,c12-CLA contents. CONCLUSION: The gut microbiota analysis results, assessed in faeces, showed that Bacteroides and Citrobacter were positively correlated with CAPs, which indicated that changes in specific genera might be detrimental to intestinal health. In addition, t10,c12-CLA played an important role in protecting the intestine. BioMed Central 2021-01-12 /pmc/articles/PMC7805033/ /pubmed/33436066 http://dx.doi.org/10.1186/s13099-020-00395-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Ciyan
Niu, Min
Pan, Junxi
Du, Na
Liu, Shumin
Li, Huanqin
He, Qiuyue
Mao, Jian
Duan, Yong
Du, Yan
Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients
title Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients
title_full Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients
title_fullStr Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients
title_full_unstemmed Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients
title_short Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients
title_sort bacteroides, butyric acid and t10,c12-cla changes in colorectal adenomatous polyp patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805033/
https://www.ncbi.nlm.nih.gov/pubmed/33436066
http://dx.doi.org/10.1186/s13099-020-00395-0
work_keys_str_mv AT chenciyan bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients
AT niumin bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients
AT panjunxi bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients
AT duna bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients
AT liushumin bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients
AT lihuanqin bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients
AT heqiuyue bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients
AT maojian bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients
AT duanyong bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients
AT duyan bacteroidesbutyricacidandt10c12clachangesincolorectaladenomatouspolyppatients